Envestnet Portfolio Solutions, Inc. Bio Rad Laboratories, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $24.4 Billion
- Q2 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 978 shares of BIO stock, worth $296,167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
978
Previous 1,293
24.36%
Holding current value
$296,167
Previous $314,000
24.84%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BIO
# of Institutions
427Shares Held
19.1MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$762 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$559 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$470 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$303 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$261 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.46B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...